Search Results

There are 8728 results for: content related to: Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies

  1. You have full text access to this OnlineOpen article
    IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment

    EMBO Molecular Medicine

    Volume 8, Issue 2, February 2016, Pages: 155–170, Mario Catarinella, Andrea Monestiroli, Giulia Escobar, Amleto Fiocchi, Ngoc Lan Tran, Roberto Aiolfi, Paolo Marra, Antonio Esposito, Federica Cipriani, Luca Aldrighetti, Matteo Iannacone, Luigi Naldini, Luca G Guidotti and Giovanni Sitia

    Version of Record online : 14 JAN 2016, DOI: 10.15252/emmm.201505395

  2. You have free access to this content
    Establishment of interferon alpha-resistant hepatitis C virus using cell culture system

    FEBS Letters

    Volume 585, Issue 2, January 21, 2011, Pages: 409–413, Huong T.L. Tran, Yun-Sook Lim and Soon B. Hwang

    Version of Record online : 28 DEC 2010, DOI: 10.1016/j.febslet.2010.12.028

  3. You have free access to this content
    Multiple signaling cascades are differentially involved in gene induction by double stranded RNA in interferon-α-primed cells

    European Journal of Biochemistry

    Volume 268, Issue 5, March 2001, Pages: 1373–1381, Jennifer L. Harcourt and Margaret K. Offermann

    Version of Record online : 5 APR 2002, DOI: 10.1046/j.1432-1327.2001.02003.x

  4. You have full text access to this OnlineOpen article
    Type I interferon rapidly restricts infectious hepatitis C virus particle genesis

    Hepatology

    Volume 60, Issue 6, December 2014, Pages: 1891–1901, Luke W. Meredith, Michelle J. Farquhar, Alexander W. Tarr and Jane A. McKeating

    Version of Record online : 27 OCT 2014, DOI: 10.1002/hep.27333

  5. You have free access to this content
    HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 127–132, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12404

  6. You have full text access to this OnlineOpen article
    Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 288–294, Nicole C.C. Them, Klaudia Bagienski, Tiina Berg, Bettina Gisslinger, Martin Schalling, Doris Chen, Veronika Buxhofer-Ausch, Josef Thaler, Ernst Schloegl, Guenther A. Gastl, Dominik Wolf, Karin Strecker, Alexander Egle, Thomas Melchardt, Sonja Burgstaller, Ella Willenbacher, Oleh Zagrijtschuk, Christoph Klade, Richard Greil, Heinz Gisslinger and Robert Kralovics

    Version of Record online : 2 MAR 2015, DOI: 10.1002/ajh.23928

  7. You have free access to this content
    Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2774–2784, Atsushi Hosui, Peter Klover, Tomohide Tatsumi, Akio Uemura, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Naoki Hiramatsu, Tatsuya Kanto, Lothar Hennighausen, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 28 JUN 2012, DOI: 10.1002/ijc.27580

  8. You have free access to this content
    PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7–Induced Type I Interferon in Systemic Lupus Erythematosus

    Arthritis & Rheumatology

    Volume 67, Issue 9, September 2015, Pages: 2403–2414, Yaya Wang, David Ewart, Juliet N. Crabtree, Ami Yamamoto, Emily C. Baechler, Parastoo Fazeli and Erik J. Peterson

    Version of Record online : 26 AUG 2015, DOI: 10.1002/art.39211

  9. Systematic review with meta-analysis: comparison between therapeutic regimens for paediatric chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 1, July 2015, Pages: 12–19, A. El Sherbini, S. Mostafa and E. Ali

    Version of Record online : 30 APR 2015, DOI: 10.1111/apt.13221

  10. You have free access to this content
    Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling

    The FEBS Journal

    Volume 277, Issue 22, November 2010, Pages: 4741–4754, Tim Maiwald, Annette Schneider, Hauke Busch, Sven Sahle, Norbert Gretz, Thomas S. Weiss, Ursula Kummer and Ursula Klingmüller

    Version of Record online : 21 OCT 2010, DOI: 10.1111/j.1742-4658.2010.07880.x

  11. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo

    Glia

    Volume 60, Issue 10, October 2012, Pages: 1555–1566, Parul Kapil, Niranjan B. Butchi, Stephen A. Stohlman and Cornelia C. Bergmann

    Version of Record online : 26 JUN 2012, DOI: 10.1002/glia.22375

  12. You have free access to this content
    Light on the Horizont: biologicals in Behçet uveitis

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: 297–306, Dicle Hazirolan, Nicole Stübiger and Uwe Pleyer

    Version of Record online : 20 APR 2012, DOI: 10.1111/j.1755-3768.2011.02348.x

  13. Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

    Journal of Viral Hepatitis

    Volume 19, Issue 9, September 2012, Pages: 623–634, S. Pianko, S. Zeuzem, W.-L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.-M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson and for the B2202 Study Team

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01586.x

  14. You have free access to this content
    Toll-Like Receptor 3 and 7/8 Function Is Impaired in Hepatitis C Rapid Fibrosis Progression Post-Liver Transplantation

    American Journal of Transplantation

    Volume 13, Issue 4, April 2013, Pages: 943–953, J. Howell, R. Sawhney, N. Skinner, P. Gow, P. Angus, D. Ratnam and K. Visvanathan

    Version of Record online : 20 FEB 2013, DOI: 10.1111/ajt.12165

  15. You have free access to this content
    B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren’s Syndrome

    Scandinavian Journal of Immunology

    Volume 67, Issue 2, February 2008, Pages: 185–192, F. Lavie, C. Miceli-Richard, M. Ittah, J. Sellam, J.-E. Gottenberg and X. Mariette

    Version of Record online : 11 JAN 2008, DOI: 10.1111/j.1365-3083.2007.02049.x

  16. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review

    Journal of Viral Hepatitis

    Volume 20, Issue 9, September 2013, Pages: 593–599, A. Raza, S. Mittal and G. K. Sood

    Version of Record online : 5 AUG 2013, DOI: 10.1111/jvh.12135

  17. You have free access to this content
    Optimal therapy of chronic hepatitis B: how do I treat HBeAg-positive patients?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 100–106, Jiannis Vlachogiannakos and George V. Papatheodoridis

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12719

  18. You have free access to this content
    The vav proto-oncogene product (p95vav) interacts with the Tyk-2 protein tyrosine kinase

    FEBS Letters

    Volume 403, Issue 1, February 10, 1997, Pages: 31–34, Shahab Uddin, Michelle Sweet, Oscar R Colamonici, John J Krolewski and Leonidas C Platanias

    Version of Record online : 3 NOV 1997, DOI: 10.1016/S0014-5793(97)00023-9

  19. Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA

    European Journal of Clinical Investigation

    Volume 45, Issue 9, September 2015, Pages: 918–924, Enagnon Kazali Alidjinou, Wassim Chehadeh, Jacques Weill, Marie-Christine Vantyghem, Chantal Stuckens, Anne Decoster, Christine Hober and Didier Hober

    Version of Record online : 6 AUG 2015, DOI: 10.1111/eci.12485

  20. You have full text access to this OnlineOpen article
    Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 8, August 2015, Pages: 1795–1804, Igor Tsaur, Lukasz Hudak, Jasmina Makarević, Eva Juengel, Jens Mani, Hendrik Borgmann, Kilian M. Gust, David Schilling, Georg Bartsch, Karen Nelson, Axel Haferkamp and Roman A. Blaheta

    Version of Record online : 26 MAR 2015, DOI: 10.1111/jcmm.12583